Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Correspondence:
View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barber, P. A.
Right arrow Articles by Buchan, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barber, P. A.
Right arrow Articles by Buchan, A. M.
Neurology 2001;56:1015-1020
© 2001 American Academy of Neurology
Articles

Why are stroke patients excluded from TPA therapy?

An analysis of patient eligibility

P. A. Barber, MRCP (UK);, J. Zhang, MSc;, A. M. Demchuk, MD;, M. D. Hill, MD; and A. M. Buchan, FRCP

From the Department of Clinical Neurosciences, University of Calgary, Alberta, Canada.

Address correspondence and reprint requests to Dr. A.M. Buchan, Foothills Medical Centre, Rm. 1162, 1403 29 St. NW, Calgary, Alberta, Canada T2M 2T9; e-mail: buchan{at}ucalgary.ca

BACKGROUND: Thrombolytic therapy for acute stroke (<3 hours) will not have a major impact on death and dependency unless it is accessible to more patients.

OBJECTIVE: To determine why patients with ischemic stroke did not receive IV TPA and assess the availability of this therapy to patients with ischemic stroke.

METHODS: Consecutive patients with acute ischemic stroke were prospectively identified at a university teaching hospital between October 1996 and December 1999. Additional patients with ischemic stroke were identified that were admitted to one of three other hospitals in the Calgary region during the study period. The Oxford Community Stroke Programme Classification was used to record type and side of stroke.

RESULTS: Of 2165 stroke patients presenting to the university hospital, 1168 (53.9%) were diagnosed with ischemic stroke, 31.8% with intracranial hemorrhage (intracerebral, subarachnoid, or subdural), and 13.9% with TIA. Delay in presentation to emergency department beyond 3 hours excluded 73.1% (854/1168). Major reasons for delay included uncertain time of onset (24.2%), patients waited to see if symptoms would improve (29%), delay caused by transfer from an outlying hospital (8.9%), and inaccessibility of treating hospital (5.7%). Twenty-seven percent of patients with ischemic stroke (314/1168) were admitted within 3 hours of sympton onset and of these 84 (26.7%) patients received IV TPA. The major reasons for exclusion in this group of patients (<3 hours) were mild stroke (13.1%), clinical improvement (18.2%), perceived protocol exclusions (13.6%), emergency department referral delay (8.9%), and significant comorbidity (8.3%). Of those patients who were considered too mild or were documented to have had significant improvement, 32% either remained dependent at hospital discharge or died during hospital admission. Throughout the region there was a total of 1806 ischemic stroke patients (admitted to all four Calgary hospitals). During this study period, 4.7% received IV TPA.

CONCLUSIONS: The majority of patients are unable to receive TPA for acute ischemic stroke because they do no not reach the hospital soon enough. Of those patients presenting within 3 hours, 27% received the therapy but a further 31% were excluded because their symptoms were either considered too mild or were rapidly improving. Subsequently, a third of these patients were left either dependent or dead, bringing into question the initial decision not to treat.




This article has been cited by other articles:


Home page
 NeurologyHome page
S. Sato, K. Toyoda, T. Uehara, N. Toratani, C. Yokota, H. Moriwaki, H. Naritomi, and K. Minematsu
Baseline NIH Stroke Scale Score predicting outcome in anterior and posterior circulation strokes
Neurology, June 10, 2008; 70(24_Part_2): 2371 - 2377.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
N. P. de la Ossa, J. Sanchez-Ojanguren, E. Palomeras, M. Millan, J. F. Arenillas, L. Dorado, C. Guerrero, S. Abilleira, and A. Davalos
Influence of the stroke code activation source on the outcome of acute ischemic stroke patients
Neurology, April 8, 2008; 70(15): 1238 - 1243.
[Abstract] [Full Text] [PDF]

Home page
 QJMHome page
M. T. McCormick, I. Reeves, T. Baird, I. Bone, and K. W. Muir
Implementation of a stroke thrombolysis service within a tertiary neurosciences centre in the United Kingdom
QJM, April 1, 2008; 101(4): 291 - 298.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
A. Kunz, T. Abe, K. Hochrainer, M. Shimamura, J. Anrather, G. Racchumi, P. Zhou, and C. Iadecola
Nuclear Factor-{kappa}B Activation and Postischemic Inflammation Are Suppressed in CD36-Null Mice after Middle Cerebral Artery Occlusion
J. Neurosci., February 13, 2008; 28(7): 1649 - 1658.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
J. Juhl Majersik, M. A. Smith, D. B. Zahuranec, B. N. Sanchez, and L. B. Morgenstern
Population-Based Analysis of the Impact of Expanding the Time Window for Acute Stroke Treatment
Stroke, December 1, 2007; 38(12): 3213 - 3217.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
M. Kaste
Do Not Wait, Act Now
Stroke, December 1, 2007; 38(12): 3119 - 3120.
[Full Text] [PDF]

Home page
 StrokeHome page
P. D. Schellinger, G. Thomalla, J. Fiehler, M. Kohrmann, C. A. Molina, T. Neumann-Haefelin, M. Ribo, O. C. Singer, O. Zaro-Weber, and J. Sobesky
MRI-Based and CT-Based Thrombolytic Therapy in Acute Stroke Within and Beyond Established Time Windows: An Analysis of 1210 Patients
Stroke, October 1, 2007; 38(10): 2640 - 2645.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
J. De Keyser, Z. Gdovinova, M. Uyttenboogaart, P. C. Vroomen, and G. J. Luijckx
Intravenous Alteplase for Stroke: Beyond the Guidelines and in Particular Clinical Situations
Stroke, September 1, 2007; 38(9): 2612 - 2618.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
K. Nedeltchev, B. Schwegler, T. Haefeli, C. Brekenfeld, J. Gralla, U. Fischer, M. Arnold, L. Remonda, G. Schroth, and H. P. Mattle
Outcome of Stroke With Mild or Rapidly Improving Symptoms
Stroke, September 1, 2007; 38(9): 2531 - 2535.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
S. Prabhakaran, J. Y. Chong, and R. L. Sacco
Impact of Abnormal Diffusion-Weighted Imaging Results on Short-term Outcome Following Transient Ischemic Attack
Arch Neurol, August 1, 2007; 64(8): 1105 - 1109.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
B. Jarrell, A. Tadros, C. Whiteman, T. Crocco, and S. M. Davis
National Healthline Responses to a Stroke Scenario: Implications for Early Intervention
Stroke, August 1, 2007; 38(8): 2376 - 2378.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
S. M. Davis
Community Stroke Education Using Mass Media: Past Results and Future Implications
Stroke, July 1, 2007; 38(7): 2034 - 2035.
[Full Text] [PDF]

Home page
 StrokeHome page
T. R. Yip and B. M. Demaerschalk
Estimated Cost Savings of Increased Use of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in Canada
Stroke, June 1, 2007; 38(6): 1952 - 1955.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
R. J. Gibbons
Leading the Elephant Out of the Corner: The Future of Health Care: Presidential Address at the American Heart Association 2006 Scientific Sessions
Circulation, April 24, 2007; 115(16): 2221 - 2230.
[Full Text] [PDF]

Home page
 Emerg. Med. J.Home page
A. Kobayashi, M. Skowronska, T. Litwin, and A. Czlonkowska
Lack of experience of intravenous thrombolysis for acute ischaemic stroke does not influence the proportion of patients treated
Emerg. Med. J., February 1, 2007; 24(2): 96 - 99.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
A. Aleu, P. Mellado, C. Lichy, M. Kohrmann, and P. D. Schellinger
Hemorrhagic Complications After Off-Label Thrombolysis for Ischemic Stroke
Stroke, February 1, 2007; 38(2): 417 - 422.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
P. D. Lyden
January 23 Highlight and Commentary: Using tPA for acute stroke in a rural setting
Neurology, January 23, 2007; 68(4): 247 - 247.
[Full Text] [PDF]

Home page
 StrokeHome page
J. A. Sattin, S. E. Olson, L. Liu, R. Raman, and P. D. Lyden
An Expedited Code Stroke Protocol Is Feasible and Safe
Stroke, December 1, 2006; 37(12): 2935 - 2939.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
V. Rajajee, C. Kidwell, S. Starkman, B. Ovbiagele, J. R. Alger, P. Villablanca, F. Vinuela, G. Duckwiler, R. Jahan, A. Fredieu, et al.
Early MRI and outcomes of untreated patients with mild or improving ischemic stroke.
Neurology, September 26, 2006; 67(6): 980 - 984.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
K. Z. Bambauer, S. C. Johnston, D. E. Bambauer, and J. A. Zivin
Reasons why few patients with acute stroke receive tissue plasminogen activator.
Arch Neurol, May 1, 2006; 63(5): 661 - 664.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
L. Mandelzweig, U. Goldbourt, V. Boyko, and D. Tanne
Perceptual, Social, and Behavioral Factors Associated With Delays in Seeking Medical Care in Patients With Symptoms of Acute Stroke
Stroke, May 1, 2006; 37(5): 1248 - 1253.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
C. R. Baumann, R. W. Baumgartner, J. Gandjour, H.-C. von Budingen, A. M. Siegel, and D. Georgiadis
Good Outcomes in Ischemic Stroke Patients Treated With Intravenous Thrombolysis Despite Regressing Neurological Symptoms
Stroke, May 1, 2006; 37(5): 1332 - 1333.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
S. C. Jones, A. Kharlamov, B. Yanovski, D. K. Kim, K. A. Easley, V. E. Yushmanov, S. K. Ziolko, and F. E. Boada
Stroke Onset Time Using Sodium MRI in Rat Focal Cerebral Ischemia
Stroke, March 1, 2006; 37(3): 883 - 888.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
G. Thomalla, C. Schwark, J. Sobesky, E. Bluhmki, J. B. Fiebach, J. Fiehler, O. Zaro Weber, T. Kucinski, E. Juettler, P. A. Ringleb, et al.
Outcome and Symptomatic Bleeding Complications of Intravenous Thrombolysis Within 6 Hours in MRI-Selected Stroke Patients: Comparison of a German Multicenter Study With the Pooled Data of ATLANTIS, ECASS, and NINDS tPA Trials
Stroke, March 1, 2006; 37(3): 852 - 858.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
P. J. Hand, J. Kwan, R. I. Lindley, M. S. Dennis, and J. M. Wardlaw
Distinguishing Between Stroke and Mimic at the Bedside: The Brain Attack Study
Stroke, March 1, 2006; 37(3): 769 - 775.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
Y. Z. Deng, M. J. Reeves, B. S. Jacobs, G. L. Birbeck, R. U. Kothari, S. L. Hickenbottom, A. J. Mullard, S. Wehner, K. Maddox, A. Majid, et al.
IV tissue plasminogen activator use in acute stroke: Experience from a statewide registry
Neurology, February 14, 2006; 66(3): 306 - 312.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
J. H. Choi, B. T. Bateman, S. Mangla, R. S. Marshall, S. Prabhakaran, J. Chong, J. P. Mohr, H. Mast, and J. Pile-Spellman
Endovascular Recanalization Therapy in Acute Ischemic Stroke
Stroke, February 1, 2006; 37(2): 419 - 424.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
M. L. Flaherty, D. Woo, M. Haverbusch, C. J. Moomaw, P. Sekar, L. Sauerbeck, B. Kissela, D. Kleindorfer, and J. P. Broderick
Potential Applicability of Recombinant Factor VIIa for Intracerebral Hemorrhage
Stroke, December 1, 2005; 36(12): 2660 - 2664.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
E. E. Smith, A. R. Abdullah, I. Petkovska, E. Rosenthal, W. J. Koroshetz, and L. H. Schwamm
Poor Outcomes in Patients Who Do Not Receive Intravenous Tissue Plasminogen Activator Because of Mild or Improving Ischemic Stroke
Stroke, November 1, 2005; 36(11): 2497 - 2499.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
J. Berrouschot, J. Rother, J. Glahn, T. Kucinski, J. Fiehler, and G. Thomalla
Outcome and Severe Hemorrhagic Complications of Intravenous Thrombolysis With Tissue Plasminogen Activator in Very Old (>=80 Years) Stroke Patients
Stroke, November 1, 2005; 36(11): 2421 - 2425.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
B. M. Demaerschalk and T. R. Yip
Economic Benefit of Increasing Utilization of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in the United States
Stroke, November 1, 2005; 36(11): 2500 - 2503.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
S. B. Coutts, M. D. Hill, J. E. Simon, C. -H. Sohn, J. N. Scott, A. M. Demchuk, and for the VISION Study Group
Silent ischemia in minor stroke and TIA patients identified on MR imaging
Neurology, August 23, 2005; 65(4): 513 - 517.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
S. Di Legge, J. Fang, G. Saposnik, and V. Hachinski
The impact of lesion side on acute stroke treatment
Neurology, July 12, 2005; 65(1): 81 - 86.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
A. W. Wojner-Alexandrov, A. V. Alexandrov, D. Rodriguez, D. Persse, and J. C. Grotta
Houston Paramedic and Emergency Stroke Treatment and Outcomes Study (HoPSTO)
Stroke, July 1, 2005; 36(7): 1512 - 1518.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
A. I. Qureshi, J. F. Kirmani, M. A. Sayed, A. Safdar, S. Ahmed, R. Ferguson, L. A. Hershey, K. J. Qazi, and for the Buffalo Metropolitan Area and Erie County
Time to hospital arrival, use of thrombolytics, and in-hospital outcomes in ischemic stroke
Neurology, June 28, 2005; 64(12): 2115 - 2120.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
N U Weir and A M Buchan
A study of the workload and effectiveness of a comprehensive acute stroke service
J. Neurol. Neurosurg. Psychiatry, June 1, 2005; 76(6): 863 - 865.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
D. Kleindorfer, M. D. Hill, D. Woo, T. Tomsick, A. Pancioli, B. Kissela, A. M. Demchuk, D. Losiewicz, E. Jauch, A. Schneider, et al.
A Description of Canadian and United States Physician Reimbursement for Thrombolytic Therapy Administration in Acute Ischemic Stroke
Stroke, March 1, 2005; 36(3): 682 - 687.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
California Acute Stroke Pilot Registry (CASPR) Inv
Prioritizing interventions to improve rates of thrombolysis for ischemic stroke
Neurology, February 22, 2005; 64(4): 654 - 659.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
D. Cocho, R. Belvis, J. Marti-Fabregas, L. Molina-Porcel, J. Diaz-Manera, A. Aleu, J. Pagonabarraga, D. Garcia-Bargo, A. Mauri, and J. -L. Marti-Vilalta
Reasons for exclusion from thrombolytic therapy following acute ischemic stroke
Neurology, February 22, 2005; 64(4): 719 - 720.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
V. C. Douglas, D. C. Tong, L. A. Gillum, S. Zhao, L. M. Brass, J. Dostal, and S. C. Johnston
Do the Brain Attack Coalition's criteria for stroke centers improve care for ischemic stroke?
Neurology, February 8, 2005; 64(3): 422 - 427.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
J. L. Frey, H. K. Jahnke, P. W. Goslar, S. Partovi, and M. S. Flaster
tPA by telephone: Extending the benefits of a comprehensive stroke center
Neurology, January 11, 2005; 64(1): 154 - 156.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
P. D. Schellinger
Editorial Comment--Outcome of Acute Stroke Patients Without Visible Occlusion on Early Arteriography
Stroke, May 1, 2004; 35(5): 1139 - 1140.
[Full Text] [PDF]

Home page
 StrokeHome page
S. R. Ramee, R. Subramanian, R. A. Felberg, K. L. McKinley, J. S. Jenkins, T. J. Collins, R. C. Dawson, and C. J. White
Catheter-Based Treatment for Patients With Acute Ischemic Stroke Ineligible for Intravenous Thrombolysis
Stroke, May 1, 2004; 35(5): e109 - e111.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
I. L. Katzan, M. D. Hammer, E. D. Hixson, A. J. Furlan, A. Abou-Chebl, and D. M. Nadzam
Utilization of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke
Arch Neurol, March 1, 2004; 61(3): 346 - 350.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
K.-C. Chang, M.-C. Tseng, and T.-Y. Tan
Prehospital Delay After Acute Stroke in Kaohsiung, Taiwan
Stroke, March 1, 2004; 35(3): 700 - 704.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
J. Kennedy and A.M. Buchan
Acute Neurovascular Syndromes: Hurry Up, Please, It's Time1
Stroke, February 1, 2004; 35(2): 360 - 362.
[Full Text] [PDF]

Home page
 StrokeHome page
S. B. Coutts, P. A. Barber, A. M. Demchuk, M. D. Hill, J.H. W. Pexman, M. E. Hudon, and A. M. Buchan
Mild Neurological Symptoms Despite Middle Cerebral Artery Occlusion
Stroke, February 1, 2004; 35(2): 469 - 471.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
D. Kleindorfer, B. Kissela, A. Schneider, D. Woo, J. Khoury, R. Miller, K. Alwell, J. Gebel, J. Szaflarski, A. Pancioli, et al.
Eligibility for Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke: A Population-Based Study
Stroke, February 1, 2004; 35 (2): e27 - e29.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
J. G. Merino and K. M. Heilman
Editorial Comment--Measurement of Cognitive Deficits in Acute Stroke
Stroke, October 1, 2003; 34(10): 2396 - 2398.
[Full Text] [PDF]

Home page
 StrokeHome page
S. B. Coutts, J. E. Simon, A. I. Tomanek, P. A. Barber, J. Chan, M. E. Hudon, J. R. Mitchell, R. Frayne, M. Eliasziw, A. M. Buchan, et al.
Reliability of Assessing Percentage of Diffusion-Perfusion Mismatch
Stroke, July 1, 2003; 34(7): 1681 - 1683.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
May 13 Highlights
Neurology, May 13, 2003; 60(9): 1403 - 1405.
[Full Text] [PDF]

Home page
 StrokeHome page
R. Handschu, R. Poppe, J. Rauss, B. Neundorfer, and F. Erbguth
Emergency Calls in Acute Stroke
Stroke, April 1, 2003; 34(4): 1005 - 1009.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
S. L. Silliman, B. Quinn, V. Huggett, and J. G. Merino
Use of a Field-to-Stroke Center Helicopter Transport Program to Extend Thrombolytic Therapy to Rural Residents
Stroke, March 1, 2003; 34(3): 729 - 733.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
J. Rother, P.D. Schellinger, A. Gass, M. Siebler, A. Villringer, J.B. Fiebach, J. Fiehler, O. Jansen, T. Kucinski, V. Schoder, et al.
Effect of Intravenous Thrombolysis on MRI Parameters and Functional Outcome in Acute Stroke <6 Hours
Stroke, October 1, 2002; 33(10): 2438 - 2445.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
D. J. Gladstone, S. E. Black, and A. M. Hakim
Toward Wisdom From Failure: Lessons From Neuroprotective Stroke Trials and New Therapeutic Directions
Stroke, August 1, 2002; 33(8): 2123 - 2136.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
J. N. Fink, M. H. Selim, S. Kumar, B. Silver, I. Linfante, L. R. Caplan, and G. Schlaug
Is the Association of National Institutes of Health Stroke Scale Scores and Acute Magnetic Resonance Imaging Stroke Volume Equal for Patients With Right- and Left-Hemisphere Ischemic Stroke?
Stroke, April 1, 2002; 33(4): 954 - 958.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
J. N. Fink, M. H. Selim, S. Kumar, G. Schlaug, and A. M. Buchan
Why are stroke patients excluded from tPA therapy? An analysis of patient eligibility
Neurology, November 13, 2001; 57(9): 1739 - 1740.
[Full Text] [PDF]

Home page
 StrokeHome page
J. A. Chalela, I. Katzan, D. S. Liebeskind, P. Rasmussen, O. Zaidat, J. I. Suarez, D. Chiu, R. P. Klucznick, E. Jauch, B. L. Cucchiara, et al.
Safety of Intra-Arterial Thrombolysis in the Postoperative Period Editorial Comment : Safety of Intra-Arterial Thrombolysis in the Postoperative Period
Stroke, June 1, 2001; 32(6): 1365 - 1369.
[Abstract] [Full Text] [PDF]

Correspondence: